1. Phosphorylation of Sp1 in Response to DNA Damage by Ataxia Telangiectasia-Mutated Kinase
   Beatrix A. Olofsson et al, 2007, Molecular Cancer Research CrossRef
2. BRCA1 mRNA Expression Levels Predict for Overall Survival in Ovarian Cancer after Chemotherapy
   Jennifer E. Quinn et al, 2007, Clinical Cancer Research CrossRef
3. TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair
   Yimei Feng et al, 2019, Frontiers in Oncology CrossRef
4. Farnesyltransferase Inhibitors Induce DNA Damage via Reactive Oxygen Species in Human Cancer Cells
   Jingxuan Pan et al, 2005, Cancer Research CrossRef
5. BRCA1- and BRCA2-Deficient Cells Are Sensitive to Etoposide-Induced DNA Double-Strand Breaks via Topoisomerase II
   Alejandro D. Treszezamsky et al, 2007, Cancer Research CrossRef
6. Acute Chemotherapy–Related Toxicity Is Not Increased in BRCA1 and BRCA2 Mutation Carriers Treated for Breast Cancer in the United Kingdom
   Susan Shanley et al, 2006, Clinical Cancer Research CrossRef
7. Topoisomerases and cancer chemotherapy: recent advances and unanswered questions
   Mary-Ann Bjornsti et al, 2019, F1000Research CrossRef
8. Vascular Targeting and Antiangiogenesis Agents Induce Drug Resistance Effector GRP78 within the Tumor Microenvironment
   Dezheng Dong et al, 2005, Cancer Research CrossRef